Mpro/PLPro-IN-2 (Compound 22l) is a non-covalent competitive dual inhibitor of SARS-CoV-2s papain-like protease and main protease, exhibiting a Ki of 0.2 µM for the papain-like protease and 1.1 µM for the main protease. Mpro/PLPro-IN-2 is applicable in research related to anti-SARS-CoV-2 efforts.
Target:
SARS-CoV|||Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
